As CD44 and VEGF in the tumor periphery of GBM tended to be expressed in a mutually exclusive manner in terms of responsiveness to Bev therapy, we investigated whether a relationship was present between VEGF and CD44 using three GSC lines. The gene discussed is VEGFA; the disease is glioblastoma.